| 2798 |
1632: Increase in RONS |
2073: methemocyanin formation (decrease overall oxygen binding capacity) |
Nov 16, 2022 |
Nov 16, 2022 |
1 AOP
|
| 3268 |
1632: Increase in RONS |
1392: Increase, Oxidative Stress |
Jul 4, 2024 |
Jul 4, 2024 |
1 AOP
|
| 3565 |
1632: Increase in RONS |
1767: Increase, Protein oxidation |
Aug 13, 2025 |
Aug 13, 2025 |
None
|
| 3566 |
1632: Increase in RONS |
1445: Increase, LPO |
Aug 13, 2025 |
Aug 13, 2025 |
None
|
| 3567 |
1632: Increase in RONS |
1634: Increase, Oxidative DNA damage |
Aug 13, 2025 |
Aug 13, 2025 |
None
|
| 1795 |
1553: Increase mutations |
1555: Increase cell proliferation |
Dec 19, 2018 |
Dec 19, 2018 |
None
|
| 1800 |
1553: Increase mutations |
1556: Increase, lung cancer |
Dec 19, 2018 |
Dec 19, 2018 |
None
|
| 1900 |
1553: Increase mutations |
1182: Increase, Cell Proliferation (Epithelial Cells) |
May 7, 2019 |
May 7, 2019 |
None
|
| 3237 |
1553: Increase mutations |
885: Increase, Cancer |
May 28, 2024 |
May 28, 2024 |
None
|
| 2023 |
1713: Increase of autoantibody production |
1714: Exacerbation of SLE |
Dec 29, 2019 |
Aug 14, 2020 |
1 AOP
|
| 2022 |
1712: Increase of Th2 cells producing IL-4 |
1713: Increase of autoantibody production |
Dec 29, 2019 |
Aug 14, 2020 |
1 AOP
|
| 2799 |
2073: methemocyanin formation (decrease overall oxygen binding capacity) |
2074: Decrease overall oxygen binding capacity (methemocyanin formation) |
Nov 16, 2022 |
Nov 16, 2022 |
1 AOP
|
| 2800 |
2073: methemocyanin formation (decrease overall oxygen binding capacity) |
2075: Hemocyanin Bohr effect decrease |
Nov 16, 2022 |
Nov 16, 2022 |
1 AOP
|
| 2067 |
1743: Increase plasma Ang II |
1745: Increase,collagen synthesis |
Mar 17, 2020 |
Mar 17, 2020 |
None
|
| 2138 |
1743: Increase plasma Ang II |
68: Increase, Collagen accumulation |
May 15, 2020 |
May 15, 2020 |
None
|
| 2435 |
1743: Increase plasma Ang II |
1852: Increased Ang II type 1 receptor (AT1R) |
Jul 13, 2021 |
Jul 13, 2021 |
1 AOP
|
| 398 |
416: Increase proliferation, Leydig cell |
415: Hyperplasia, Leydig cell |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 2748 |
2054: Increase, impairment of cuticle sclerotization |
990: Increase, Incomplete ecdysis |
Aug 28, 2022 |
Aug 28, 2022 |
1 AOP
|
| 2749 |
2055: Increase, pigmentation |
990: Increase, Incomplete ecdysis |
Aug 28, 2022 |
Aug 28, 2022 |
1 AOP
|
| 3741 |
2410: Increase, 11β-HSD1 activity |
2412: Increase, Hepatic intracellular active GC |
Feb 24, 2026 |
Feb 24, 2026 |
6 AOPs
|
| 2836 |
2098: Abnormal Neural Remodeling |
341: Impairment, Learning and memory |
Jan 25, 2023 |
Jul 26, 2024 |
1 AOP
|
| 2091 |
1768: Increase, Abnormal osmoregulation |
1769: Increase, Body fluid overload |
Apr 30, 2020 |
Apr 30, 2020 |
1 AOP
|
| 2181 |
1768: Increase, Abnormal osmoregulation |
1809: Increase, Tissue/organ damage |
Nov 2, 2020 |
Nov 2, 2020 |
None
|
| 3290 |
1768: Increase, Abnormal osmoregulation |
2238: Increased, Blood viscosity |
Jul 8, 2024 |
Dec 3, 2024 |
None
|
| 3722 |
2408: Increase, Adipose lipolysis |
115: Increase, FA influx |
Feb 10, 2026 |
Feb 10, 2026 |
None
|